Abstract 5584: Experimental ‘loss-of function’ annotation of STK11 mutations with prognostic and therapeutic implications (TNG260mutationfinder.com)
Leanne G. Ahronian(Harvard University), Teng Teng(Wuhan University), Iga Sienczylo(Io Therapeutics (United States)), Yi Yu(Novartis (United States)), Andre Mignault(Novartis (United States)), Shangtao Liu(Tango Therapeutics (United States)), Lauren E. Flynn(Western University), Silvia Fenoglio(Tango Therapeutics (United States)), Lauren Grove(Tango Therapeutics (United States)), Samuel R. Meier, Hannah Stowe(Massachusetts General Hospital), B.W. Shen(Io Therapeutics (United States)), Hsin‐Jung Wu(Tango Therapeutics (United States)), Preksha Shahagadkar(Io Therapeutics (United States)), Heather DiBenedetto(Io Therapeutics (United States))
Cited by 0